Multiple sclerosis and COVID-19: interactions and unresolved issues

The Lancet Neurology, Год журнала: 2025, Номер 24(4), С. 361 - 370

Опубликована: Март 20, 2025

Язык: Английский

---

Causal association between multiple sclerosis and severe COVID-19: A bidirectional Mendelian randomization study

Journal of Neuroimmunology, Год журнала: 2024, Номер 391, С. 578352 - 578352

Опубликована: Апрель 30, 2024

Язык: Английский

---

The lung-brain axis in multiple sclerosis: Mechanistic insights and future directions

Brain Behavior & Immunity - Health, Год журнала: 2024, Номер 38, С. 100787 - 100787

Опубликована: Май 3, 2024

Multiple sclerosis is a chronic inflammatory demyelinating disease of the central nervous system with progressive lifelong disability. Current treatments are particularly effective at early stage but associate safety concerns such as increased risk infection. While clinical and epidemiological evidence strongly support role bidirectional communication between lung brain in MS influencing severity, exact processes underlying relationship appear complex not fully understood. This short review aims to summarize key findings future perspectives that might provide new insights into mechanisms underpinning lung-brain axis MS.

Язык: Английский

---

Reassuring Insights Into the Effect of COVID-19 on Symptoms and Disability in People With Multiple Sclerosis

Neurology, Год журнала: 2024, Номер 104(2)

Опубликована: Дек. 23, 2024

Язык: Английский

---